We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The treatment group had a 68% improvement in ...

Please provide your email address to receive an email when new articles are posted on . Eyes with the insert had significantly less corneal and conjunctival staining at week 4, the latter of which ...

LONDON and NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of ...

The key to diagnosing and managing dry eye syndrome (DES) lies in staging the condition with proven tools, addressing the patient's symptoms, and using evidence-based approaches to treatment. This is ...

IRVINE, Calif., June 8 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) , today announced positive results from a proof-of-concept Phase 2 clinical ...

Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye. This was a phase 4, single-arm, multicenter ...

A research team demonstrated non-invasive imaging of conjunctival goblet cells (CGCs) in live rabbit eyes for the diagnosis of ocular surface diseases including dry eye disease (DED). A Korean ...